title: Total oligomeric flavonoids of Cyperus rotundus ameliorates neurological deficits, excitotoxicity and behavioral alterations induced by cerebral ischemic-reperfusion injury in rats.
abstract: Interactions between neurons and astrocytes play a critical role in the central nervous system homeostasis. Cyperus rotundus (family: Cyperaceae), a traditional Indian medicinal herb, used as nervine tonic and nootropic in the Ayurvedic system of medicine. The present study was undertaken to investigate the neuroprotective effect of total oligomeric flavonoids (TOFs), prepared from C. rotundus, in rat model of cerebral ischemia and reperfusion. Male Sprague Dawley rats (290-340g) were subjected to middle cerebral artery occlusion (MCAO) for 2h and reperfusion for 70h. Experimental animals were divided into four groups: Group I - sham operated (n=7); Group II - vehicle treated ischemic-reperfusion (IR) (n=9), and Group III and IV - TOFs treated (100 and 200mg/kg body weight, p.o., respectively; n=7 in each group). Vehicle or TOFs were pretreated for four days before the induction of ischemia and continued for next three days after the ischemia i.e. treatment was scheduled totally for a period of 7 days. MCAO surgery was performed on day 4, 1h after TOFs administration. Neuroprotective effect of TOFs was substantiated in terms of neurological deficits, excitotoxicity (glutamate, glutamine synthetase and Na(+)K(+)ATPase levels), oxidative stress (malondialdehyde, super oxide dismutase, and glutathione) and neurobehavioral functions in the experimental animals. TOFs decreased glutamate, glutamine synthetase (GS) and increased Na(+)K(+)ATPase activity in a dose dependent manner when compared to the IR rats. Treatment with TOFs significantly reduced the neurological deficits and reversed the anxiogenic behavior in rats. Further, it also significantly decreased MDA and increased superoxide dismutase (SOD) and glutathione content in brains of experimental rats. Histopathological examination using cresyl violet staining revealed the attenuation of neuronal loss by TOFs in stroke rats. The present study demonstrates the unswerving involvement of TOFs on ischemia-reperfusion triggered biochemical alterations in MCAO/R rats. Hence, TOFs might be an attractive candidate for further studies in the development of new drugs for cerebral stroke treatment.
authors.affiliation: Centre for Toxicology and Developmental Research (CEFT), Sri Ramachandra University, Chennai, Tamilnadu, India. ceftpublications@gmail.com
authors.forename: A G
authors.initials: AG
authors.lastname: Sunil
authors.forename: K S
authors.initials: KS
authors.lastname: Kesavanarayanan
authors.forename: P
authors.initials: P
authors.lastname: Kalaivani
authors.forename: S
authors.initials: S
authors.lastname: Sathiya
authors.forename: V
authors.initials: V
authors.lastname: Ranju
authors.forename: R Jyothi
authors.initials: RJ
authors.lastname: Priya
authors.forename: B
authors.initials: B
authors.lastname: Pramila
authors.forename: F D Solomon
authors.initials: FD
authors.lastname: Paul
authors.forename: J
authors.initials: J
authors.lastname: Venkhatesh
authors.forename: C Saravana
authors.initials: CS
authors.lastname: Babu
mesh_terms: D000818:Animals; D001253:Astrocytes / Q000187:drug effects / Q000378:metabolism; D001522:Behavior, Animal / Q000187:drug effects; D002545:Brain Ischemia / Q000188:drug therapy* / Q000503:physiopathology*; D029786:Cyperus / Q000737:chemistry*; D005419:Flavonoids / Q000737:chemistry* / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D020244:Infarction, Middle Cerebral Artery; D008297:Male; D008315:Malondialdehyde / Q000378:metabolism; D008515:Medicine, Ayurvedic; D009474:Neurons / Q000187:drug effects / Q000378:metabolism; D018696:Neuroprotective Agents / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D018384:Oxidative Stress / Q000187:drug effects; D051381:Rats; D017207:Rats, Sprague-Dawley; D015427:Reperfusion Injury / Q000188:drug therapy* / Q000503:physiopathology*
chemical_list: D005419:Flavonoids; D018696:Neuroprotective Agents; D008315:Malondialdehyde